CDH1 and neoplasm: The increased tumor proliferation and metastasis observed in patients with non-IBC are attributed to the loss of E-cadherin expression [65], whereas the disease aggressiveness detected in patients with IBC is attributed to upregulation of the E-cadherin epithelial marker [66].